Tyrosine Kinase and PD-1 Inhibitors Boost Liver Cancer Treatment
In a groundbreaking study poised to reshape therapeutic strategies for hepatocellular carcinoma (HCC), researchers have demonstrated the superior efficacy and safety of combining tyrosine kinase...
















